Synta Announces Presentation of Ganetespib Results at the 2013 European

Synta Announces Presentation of Ganetespib Results at the 2013 European
Drugs targeting the Hsp90 chaperone protein silence a broad network of cancer-promoting proteins, creating a wide range of potential biomarkers for selecting patients. The GALAXY-1 trial was designed to enroll a … To evaluate this hypothesis …
Read more on DailyFinance

 

Suspected gang members arrested for assault
"You got the drugs and the gangs, and essentially the motive in this isn't gangs; it's actually drugs, but some of our local gangs deal drugs," Budreau said. "This victim, bottom line — she chose to engage in drug use with these very dangerous …
Read more on Mail Tribune

 

Personalized Medicine May Be Good For Patients But Bad For Drug Companies
Personalized Medicine May Be Good For Patients But Bad For Drug Companies' Bottom Line … These side effects, which can be not only unpleasant but life-threatening, include nausea, slowed breathing, sedation, itchiness and potential for addiction …
Read more on Forbes

 

Mental health workers brace for wave of problem gamblers
… communications director for the Massachusetts Council on Compulsive Gambling. "When someone calls our help line, it's hard to find services for them. We definitely need to build … The council and the state Department of Public Health are working …
Read more on Worcester Telegram